NEW YORK, July 25, 2013 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG), a diversified life sciences company focused on proprietary biotherapeutics and diagnostics, novel medical devices and consumer healthcare businesses, has today announced the appointment of ProActive Capital Group as its new Capital Markets Advisory and Digital Media Strategies firm. Tauriga will utilize ProActive Capital's well-established relationships with the investment communities to assist the company in fostering productive relationships with analysts, brokers, potential investors, and other financial professionals, as well as to manage its unique digital media program.
"As we continue to implement our growth strategy, we are very pleased to have retained the services of ProActive Capital Group, a leading life sciences advisory firm," Tauriga's CEO Seth M. Shaw stated. "ProActive Capital has an outstanding track record in helping to convey the value of biotech companies to the investment and media communities. We believe the timing is right to articulate our investment thesis to expand our reach and increase our visibility with key stakeholders. We look forward to embarking on a significant new and expanded strategy so that we can achieve a fair valuation that clearly reflects the intrinsic value of our scientific initiatives."
"We are delighted to have been selected by Tauriga Sciences, a leading company in the proprietary biotherapeutics and diagnostics market," stated Jeff Ramson, Founder and CEO of ProActive Capital Group. "We look forward to developing and implementing a quality capital markets and digital media strategy to increase Tauriga's visibility and build its brand among the key audience segments including the investment and media communities."
About Tauriga Sciences, Inc.
Tauriga Sciences, Inc. (TAUG) is a life sciences company that focuses on proprietary biotherapeutics and diagnostics, novel medical devices and consumer healthcare. The mission of the Company is to acquire and build a diversified portfolio of medical technology assets that is capital efficient and of significant value to the shareholders. The Company's business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. The Company's new corporate website can be found at www.taurigasciences.com.
About ProActive Capital Group, LLC
ProActive Capital Group, LLC ("PCG") is dedicated to the discovery and creation of value, specifically in the emerging public company marketplace. PCG provides a unique service that combines capital market advisory services with traditional and social/digital media communications. The firm's overarching goal is to develop and maintain stakeholder awareness from all constituents in order to maximize shareholder value. PCG's capital market advisory services include key strategies to increase corporate transparency and credibility for companies across all sectors. The firm's communications services leverage traditional, digital and social media channels to further increase awareness through proprietary and best-of-breed media strategies. Communicating the client's story accurately and effectively to a wide but concentrated audience is tantamount to maximizing exposure to its current and potential shareholders. For more information: www.proactivecapital.com.